Clinical Trial Update: Open-Label Safety and Tolerability of Oxymorphone IR and ER in Opioid Tolerant Pediatric Subjects [Phase 3]

View source ↗

Summary

Open-label safety and tolerability study of oxymorphone immediate-release and extended-release in opioid-tolerant pediatric subjects was terminated; results pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pain

Drugs mentioned

• Oxymorphone (oxymorphone)

Snippet

Sponsor: Endo Pharmaceuticals | Conditions: Chronic Pain | Phase 3 | Status: TERMINATED | Results posted: 2020-12-16